Determinants of human and mouse melanoma cell sensitivities to oleandrin

Yun Lin1, William P Dubinsky, Dah H Ho

  • 1Postdoctoral Intramural Research Training Award Program, National Institute of Aging, National Institutes of Health, Baltimore, MD 21224, USA. liny2@mail.nih.gov

Insights

Oleandrin, a cardiac glycoside, effectively induces apoptosis in human tumor cells but not mouse cells. Differences in Na+, K(+)-ATPase activity, isoforms, and drug uptake explain this sensitivity variation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Oleandrin, a cardiac glycoside from Nerium oleander, induces apoptosis in malignant cells.
  • Human tumor cells show high sensitivity to oleandrin, while murine tumor cells exhibit extreme resistance.

Purpose of the Study:

  • To explore determinants of cell sensitivity to oleandrin and ouabain.
  • To compare sensitivity between human BRO and mouse B16 melanoma cell lines.

Main Methods:

  • Investigated Na+, K(+)-ATPase activity and its isoforms.
  • Assessed cellular uptake of oleandrin and ouabain.
  • Utilized Western blot analysis to identify Na+, K(+)-ATPase isoforms.

Main Results:

  • Oleandrin and ouabain induced apoptosis in BRO cells, but not B16 cells, even at 1000-fold higher concentrations.
  • Cellular uptake of oleandrin and ouabain was 3-4 fold greater in human BRO cells compared to murine B16 cells.
  • Human BRO cells expressed both alpha3 and alpha1 Na+, K(+)-ATPase isoforms, while B16 cells only expressed the alpha1 isoform.

Conclusions:

  • Differential expression of Na+, K(+)-ATPase isoforms contributes to varying tumor cell sensitivity to cardiac glycosides.
  • Cellular drug uptake levels are significant determinants of cardiac glycoside efficacy in tumor cells.